Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

How fibroblast growth factor 23 works.

Liu S, Quarles LD.

J Am Soc Nephrol. 2007 Jun;18(6):1637-47. Review.

2.
3.
4.

Overview of the FGF23-Klotho axis.

Kuro-o M.

Pediatr Nephrol. 2010 Apr;25(4):583-90. doi: 10.1007/s00467-009-1260-4. Review.

PMID:
19626341
5.

The role of bone in phosphate metabolism.

Fukumoto S.

Mol Cell Endocrinol. 2009 Oct 30;310(1-2):63-70. doi: 10.1016/j.mce.2008.08.031. Review.

PMID:
18822343
6.

Clinical practice. Fibroblast growth factor (FGF)23: a new hormone.

Alon US.

Eur J Pediatr. 2011 May;170(5):545-54. doi: 10.1007/s00431-010-1382-5. Review.

PMID:
21193927
7.

Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice.

Stubbs JR, Liu S, Tang W, Zhou J, Wang Y, Yao X, Quarles LD.

J Am Soc Nephrol. 2007 Jul;18(7):2116-24.

8.

Fibroblast growth factor 23 and its receptors.

Yu X, White KE.

Ther Apher Dial. 2005 Aug;9(4):308-12. Review.

PMID:
16076372
9.

[Disorders of phosphate metabolism].

Fukumoto S.

Rinsho Byori. 2010 Mar;58(3):225-31. Review. Japanese.

PMID:
20408440
11.

1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport.

Kolek OI, Hines ER, Jones MD, LeSueur LK, Lipko MA, Kiela PR, Collins JF, Haussler MR, Ghishan FK.

Am J Physiol Gastrointest Liver Physiol. 2005 Dec;289(6):G1036-42.

12.

Role of fibroblast growth factor 23 in health and in chronic kidney disease.

Fukagawa M, Nii-Kono T, Kazama JJ.

Curr Opin Nephrol Hypertens. 2005 Jul;14(4):325-9. Review.

PMID:
15930999
14.

Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D.

Liu S, Tang W, Zhou J, Stubbs JR, Luo Q, Pi M, Quarles LD.

J Am Soc Nephrol. 2006 May;17(5):1305-15.

15.

Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX.

Liu S, Guo R, Simpson LG, Xiao ZS, Burnham CE, Quarles LD.

J Biol Chem. 2003 Sep 26;278(39):37419-26.

17.

Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.

Liu S, Tang W, Zhou J, Vierthaler L, Quarles LD.

Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1636-44.

18.

[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Role of FGF23-Klotho axis in CKD-MBD].

Komaba H.

Clin Calcium. 2010 Jul;20(7):1028-36. doi: CliCa100710281036. Review. Japanese.

PMID:
20585181
19.

Emerging topics in pediatric bone and mineral disorders 2008.

McKay CP, Portale A.

Semin Nephrol. 2009 Jul;29(4):370-8. doi: 10.1016/j.semnephrol.2009.03.020. Review.

PMID:
19615558
20.

Inherited hypophosphatemic disorders in children and the evolving mechanisms of phosphate regulation.

Bastepe M, J├╝ppner H.

Rev Endocr Metab Disord. 2008 Jun;9(2):171-80. doi: 10.1007/s11154-008-9075-3. Review.

PMID:
18365315

Supplemental Content

Support Center